ReviewClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2009
The European network of Biosafety-Level-4 laboratories: enhancing European preparedness for new health threats.
Review in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- European Preparedness for Japanese Encephalitis Virus Through Alignment of Animal Health Laboratory Diagnosis.Transboundary and emerging diseases · 2025Article
- Exploring senior managers' experiences preparedness to respond to COVID-19: a qualitative study in Iran.BMC health services research · 2023Article
- Transport of High-Risk Infectious Substances: Packaging for the Transport of Category A Infectious Specimens in Spain.International journal of environmental research and public health · 2022Article
- Biosafety and biobanking: Current understanding and knowledge gaps.Biosafety and health · 2021Article
- Transportation capacity for patients with highly infectious diseases in Europe: a survey in 16 nations.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2019Review
- Harmonization of Biosafety and Biosecurity Standards for High-Containment Facilities in Low- and Middle-Income Countries: An Approach From the Perspective of Occupational Safety and Health.Frontiers in public health · 2019Review
- Status, quality and specific needs of Ebola virus diagnostic capacity and capability in laboratories of the two European preparedness laboratory networks EMERGE and EVD-LabNet.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2018Article
- Prioritization of High Consequence Viruses to Improve European Laboratory Preparedness for Cross-Border Health Threats.Advances in experimental medicine and biology · 2017Article
- Preparedness of healthcare workers at French Ebola referral centres.New microbes and new infections · 2015Article
- [Specialized clinical facilities for the treatment of highly contagious, life-threatening infectious diseases : a comparison between Germany and 15 European nations].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2015Article
- Article
- BSL-3 Laboratory User Training Program at NUITM-KEMRI.Tropical medicine and health · 2014Article
- Isolation facilities for highly infectious diseases in Europe--a cross-sectional analysis in 16 countries.PloS one · 2014Article
- Challenges and Practices in Building and Implementing Biosafety and Biosecurity Programs to Enable Basic and Translational Research with Select Agents.Journal of bioterrorism & biodefense · 2013Article
- Biosafety Level-4 laboratories in Europe: opportunities for public health, diagnostics, and research.PLoS pathogens · 2013Article
- European perspective of 2-person rule for biosafety level 4 laboratories.Emerging infectious diseases · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Emerging and re-emerging infections and possible bioterrorism acts will continue to challenge both the medical community and civilian populations worldwide, urging health authorities to respond rapidly and effectively. Established in 2005, the European Community (EC)-funded European Network of Biosafety-Level-4 laboratories (Euronet-P4), which brings together the laboratories in Porton Down, London, Hamburg, Marburg, Solna, Lyon and Rome, seeks to increase international collaboration in the areas of high containment laboratory biosafety and viral diagnostic capability, to strengthen Europe's capacity to respond to an infectious disease emergency, and to offer assistance to countries not equipped with such costly facilities. Network partners have agreed on a common strategy to fill the gaps identified in the field of risk group-4 agents' laboratory diagnosis, namely the lack of standardization and of reference samples. The network has received a further 3-year funding, to offer assistance to external laboratories, and to start the planning of field activities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.